Novo Integrated Revenue vs. Current Valuation
| NVOSDelisted Stock | USD 0.04 0.01 17.57% |
For Novo Integrated profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novo Integrated to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novo Integrated Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novo Integrated's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novo Integrated Sciences over time as well as its relative position and ranking within its peers.
Novo |
Novo Integrated Sciences Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Novo Integrated's current stock value. Our valuation model uses many indicators to compare Novo Integrated value to that of its competitors to determine the firm's financial worth. Novo Integrated Sciences is rated below average in revenue category among its peers. It is rated below average in current valuation category among its peers reporting about 0.46 of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for Novo Integrated Sciences is roughly 2.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novo Integrated's earnings, one of the primary drivers of an investment's value.Novo Revenue vs. Competition
Novo Integrated Sciences is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 81.72 Billion. Novo Integrated adds roughly 12.57 Million in revenue claiming only tiny portion of equities under Health Care industry.
Novo Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Novo Integrated |
| = | 12.57 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Novo Integrated |
| = | 5.8 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Novo Current Valuation vs Competition
Novo Integrated Sciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 100.77 Billion. Novo Integrated adds roughly 5.8 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Novo Integrated Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Novo Integrated, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novo Integrated will eventually generate negative long term returns. The profitability progress is the general direction of Novo Integrated's change in net profit over the period of time. It can combine multiple indicators of Novo Integrated, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc. Novo Integrated operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 73 people.
Novo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Novo Integrated. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novo Integrated position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novo Integrated's important profitability drivers and their relationship over time.
Use Novo Integrated in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Integrated position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Integrated will appreciate offsetting losses from the drop in the long position's value.Novo Integrated Pair Trading
Novo Integrated Sciences Pair Trading Analysis
The ability to find closely correlated positions to Novo Integrated could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novo Integrated when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novo Integrated - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novo Integrated Sciences to buy it.
The correlation of Novo Integrated is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novo Integrated moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novo Integrated Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novo Integrated can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Novo Integrated position
In addition to having Novo Integrated in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |